ret proto-oncogene ; Homo sapiens






1409 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 950371 Preoperative diagnosis of occult parathyroid hyperplasia by calcium infusion in patients with multiple endocrine neoplasia, type 2a. J Clin Endocrinol Metab 1976 Aug 3
2 1390993 [Inhibition of total and active E-rosettes mediated by serum from tubercular patients]. Enferm Infecc Microbiol Clin 1992 May 1
3 1437145 Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas. Oncogene 1992 Nov 1
4 1572907 Regulation of TGF-alpha expression in human keratinocytes: PKC-dependent and -independent pathways. J Cell Physiol 1992 May 1
5 1766678 Expression of the ret proto-oncogene in human neuroblastoma cell lines and its increase during neuronal differentiation induced by retinoic acid. Oncogene 1991 Dec 3
6 2000222 Identification of the ret proto-oncogene products in neuroblastoma and leukemia cells. Oncogene 1991 Feb 1
7 2107492 2-Aminopurine abolishes EGF- and TPA-stimulated pp33 phosphorylation and c-fos induction without affecting the activation of protein kinase C. Oncogene 1990 Mar 2
8 2575183 Multiple endocrine neoplasia. Jpn J Surg 1989 Nov 1
9 2686181 [The therapeutic effectiveness of chestnut extract]. Wien Med Wochenschr 1989 Sep 15 1
10 2861094 Serotonin (5-hydroxytryptamine) in medullary thyroid carcinoma with or without pheochromocytoma. Eur J Cancer Clin Oncol 1985 Apr 1
11 2892276 Early diagnosis of and surgical strategy for adrenal medullary disease in MEN II gene carriers. Surgery 1988 Jan 1
12 3001107 Interaction of the insulin receptor kinase with serine/threonine kinases in vitro. J Cell Biochem 1985 2
13 7159390 Synthesis of retinyl phosphate mannose and dolichyl phosphate mannose from endogenous and exogenous retinyl phosphate and dolichyl phosphate in microsomal fraction. Specific decrease in endogenous retinyl phosphate mannose synthesis in vitamin A deficiency. Biochem J 1982 Oct 15 20
14 7478540 Colon carcinoma kinase-4 defines a new subclass of the receptor tyrosine kinase family. Oncogene 1995 Nov 16 1
15 7491529 Presymptomatic DNA screening in families with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma. Surgery 1995 Dec 1
16 7495285 Absence of RET proto-oncogene point mutations in sporadic hyperplastic and neoplastic lesions of the parathyroid gland. Am J Pathol 1995 Dec 5
17 7510340 Tyrosine kinase inhibitors. 2. Synthesis of 2,2'-dithiobis(1H-indole-3-alkanamides) and investigation of their inhibitory activity against epidermal growth factor receptor and pp60v-src protein tyrosine kinases. J Med Chem 1994 Mar 4 1
18 7510705 Basic fibroblast growth factor-induced low density lipoprotein receptor transcription and surface expression. Signal transduction pathways mediated by the bFGF receptor tyrosine kinase. J Biol Chem 1994 Mar 25 1
19 7532281 Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations. Mol Cell Biol 1995 Mar 2
20 7536460 Mutation of the RET protooncogene in sporadic medullary thyroid carcinoma. Genes Chromosomes Cancer 1995 Mar 2
21 7559902 Mutations of codon 918 in the RET proto-oncogene correlate to poor prognosis in sporadic medullary thyroid carcinomas. J Clin Endocrinol Metab 1995 Oct 3
22 7567689 Ret-oncogene expression correlates with neuronal differentiation of neuroblastic tumors. Pathol Res Pract 1995 Mar 5
23 7584011 Genetic aspects of multiple endocrine neoplasia types 1 and 2. Curr Opin Gen Surg 1994 3
24 7595167 The RET proto-oncogene and cancer. J Intern Med 1995 Oct 4
25 7595170 Genotype-phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium. J Intern Med 1995 Oct 2
26 7608256 The RET protooncogene in sporadic pheochromocytomas: frequent MEN 2-like mutations and new molecular defects. J Clin Endocrinol Metab 1995 Jul 2
27 7627271 Tumor-specific mutations in the tyrosine kinase domain of the RET proto-oncogene in pheochromocytomas of sporadic type. Endocr J 1995 Apr 6
28 7670926 Presymptomatic genetic screening in families with multiple endocrine neoplasia type 2. J Mol Med (Berl) 1995 May 2
29 7678053 Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A. Mol Cell Biol 1993 Jan 1
30 7685595 Tyrosine kinase activity of the ret proto-oncogene products in vitro. Biochem Biophys Res Commun 1993 Jun 15 3
31 7705835 Detection of a germline mutation at codon 918 of the RET proto-oncogene in French MEN 2B families. Hum Genet 1995 Apr 5
32 7716719 Mutational analysis of multiple endocrine neoplasia type 2A associated with Hirschsprung's disease. Surgery 1995 Apr 2
33 7845675 A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC. Oncogene 1995 Feb 2 3
34 7849700 Haplotype analysis of MEN 2 mutations. Hum Mol Genet 1994 Oct 2
35 7860065 Germline mutations of the RET proto-oncogene in eight Japanese patients with multiple endocrine neoplasia type 2A (MEN2A). Hum Genet 1995 Feb 3
36 7864888 Point mutation of the RET proto-oncogene in the TT human medullary thyroid carcinoma cell line. Biochem Biophys Res Commun 1995 Feb 27 4
37 7867726 Induction of RET proto-oncogene expression in neuroblastoma cells precedes neuronal differentiation and is not mediated by protein synthesis. Exp Cell Res 1995 Mar 8
38 7874109 RET proto-oncogene mutations in French MEN 2A and FMTC families. Hum Mol Genet 1994 Nov 1
39 7881414 Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene. Hum Mol Genet 1994 Dec 9
40 7889627 Absence of mutations in the MEN2A region of the ret proto-oncogene in non-MEN 2A phaeochromocytomas. Clin Endocrinol (Oxf) 1995 Jan 4
41 7906866 A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 1994 Jan 27 3
42 7907913 Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nat Genet 1994 Jan 1
43 7910861 [The molecular genetics of multiple endocrine neoplasia type 2A and 2B]. Nihon Rinsho 1994 Apr 2
44 7911697 Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours. Hum Mol Genet 1994 Feb 3
45 7914213 Identification of the Cys634-->Tyr mutation of the RET proto-oncogene in a pedigree with multiple endocrine neoplasia type 2A and localized cutaneous lichen amyloidosis. J Endocrinol Invest 1994 Mar 5
46 7915165 Germline RET mutations in MEN 2A and FMTC and their detection by simple DNA diagnostic tests. Hum Mol Genet 1994 Apr 2
47 7943181 Detection of RET proto-oncogene point mutations in paraffin-embedded pheochromocytoma specimens by nonradioactive single-strand conformation polymorphism analysis and direct sequencing. Am J Pathol 1994 Oct 5
48 7961113 Germ line mutations of the ret proto-oncogene in Japanese patients with multiple endocrine neoplasia type 2A and type 2B. Jpn J Cancer Res 1994 Sep 2
49 7981703 Three dinucleotide repeat polymorphisms closely linked to the RET protooncogene D10S1098, D10S1099 and D10S1100. Hum Mol Genet 1994 Jul 1
50 7987299 Somatic and MEN 2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTC:s. Hum Mol Genet 1994 Aug 2